# Calcium-channel Blocker

Subclass selectivity is not typically seen in overdose, and cardiac effects predominate:

* ↓ HR
* ↓ BP
	* ↓ Inotropy
	* ↓ SVR

## Epidemiology and Risk Factors

## Pathophysiology

* Direct ↓ inotropy
* Direct ↓ SVR
* ↓ Insulin release from β-islet cells
* ↑ Insulin resistance

### Aetiology

## Clinical Manifestations

## Diagnostic Approach and DDx

## Investigations

**Bedside**:

**Laboratory**:

**Imaging**:

**Other**:

## Management

**Resuscitation**:

:::column-margin
{{< include /includes/calcium_equiv.qmd >}}
:::

* C
	* Hypotension	
		* Fluid resuscitation
		* Calcium
			* 10mL 10% Calcium chloride
			* 30mL 10% Calcium gluconate
			* Infusion can be considered but requires close monitoring
		* Insulin
	* Bradycardia
		* Atropine
		* Cardiac pacing

:::column-margin
{{< include /includes/hiet.qmd >}}
:::

**Specific therapy**:

* Pharmacological
	* Activated charcoal
		* Within 1-hour of immediate release ingestion
		* Any time after sustained release ingestion
			* Consider multiple (Q4H) dosing
* Procedural
* Physical

**Supportive care**:

**Disposition**:

**Preventative**:


### Marginal and Ineffective Therapies

## Anaesthetic Considerations

## Complications

## Prognosis

## Key Studies


---

## References

1. Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.